<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00402376</url>
  </required_header>
  <id_info>
    <org_study_id>3212</org_study_id>
    <nct_id>NCT00402376</nct_id>
  </id_info>
  <brief_title>Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy</brief_title>
  <official_title>Effects of Combined Ventricular Unloading and Pharmacological Therapy on Left Ventricular Metabolic Dysfunction in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Service de Chirurgie Cardiaque</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut de Physiologie, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <brief_summary>
    <textblock>
      Cardiac function may improve in patients with end-stage heart failure who receive long-term
      support with ventricular assist devices (VAD). Reverse left ventricular remodeling may be
      sufficient in some cases to allow explantation of the VAD. However, some questions continue
      to await definitive answers. This study is designed to assess the myocardial recovery under
      VAD support with optimal pharmacological therapy (high doses [group I] of statins,
      beta-blockers, angiotensin-converting enzyme inhibitors versus standard doses [group II]).

      The study is a randomized, single-blind trial performed at the Department of Cardiac Surgery,
      University of Strasbourg, France. Twenty patients with end-stage heart failure who will be
      supported by VAD (Thoratec paracorporeal device) as a bridge to heart transplantation will be
      included. Reverse left ventricular remodeling and myocardial function will be studied by:
      echocardiography, respiratory mitochondrial function, exercise testing, cardiac hormonal
      function, and inflammatory response. Myocardial biopsies will be obtained at the time of VAD
      implantation and heart transplantation. The follow-up will be performed every 4 weeks during
      the VAD support period. The hypothesis of this trial is that reverse left ventricular
      remodeling and myocardial function will improve under optimal medical therapy especially by a
      high dose statin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of Myocardial Improvement (Reverse Left Ventricular Remodeling, Mitochondrial
      Respiratory Function) in Patients Supported by Ventricular Assist Device Under Optimal
      Pharmacological Therapy
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>April 2007</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mitochondrial function</measure>
    <time_frame>at implantation and explantation of VAD</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammation: IL-6; IL-8; IL-10, IL-18, TNF-α</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise testing : stress echocardiography, peak oxygen consumption</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal cardiac function: ANP, BNP</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular remodelling: echocardiography</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All those parameters will be measured in the post-operative course and every 4 weeks during all the VAD support period.</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pravastatin, Carvedilol, Perindopril</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biventricular assist device (Thoratec paracorporeal assist device)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with end-stage heart failure refractory to medical therapy and who fulfill
             criteria for VAD implantation as a bridge to heart transplantation

          -  Age &gt; 18

        Exclusion Criteria:

          -  Myocarditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Geny, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Chirurgie Cardiovasculaire - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Physiologie Clinique - Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2006</study_first_submitted>
  <study_first_submitted_qc>November 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2006</study_first_posted>
  <last_update_submitted>August 29, 2011</last_update_submitted>
  <last_update_submitted_qc>August 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2011</last_update_posted>
  <keyword>End-stage heart failure</keyword>
  <keyword>heart failure;</keyword>
  <keyword>ventricular assist device;</keyword>
  <keyword>statin;</keyword>
  <keyword>heart transplantation;</keyword>
  <keyword>myocardial function;</keyword>
  <keyword>mitochondrial respiratory function;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carvedilol</mesh_term>
    <mesh_term>Perindopril</mesh_term>
    <mesh_term>Pravastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

